# Denosumab and Male Infertility: a RCT

> **NCT03030196** · PHASE2 · COMPLETED · sponsor: **Martin Blomberg Jensen** · enrollment: 95 (estimated)

## Conditions studied

- Infertility, Male

## Interventions

- **DRUG:** Denosumab

## Key facts

- **NCT ID:** NCT03030196
- **Lead sponsor:** Martin Blomberg Jensen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2021-01
- **Final completion:** 2023-05
- **Target enrollment:** 95 (ESTIMATED)
- **Last updated:** 2023-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03030196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03030196, "Denosumab and Male Infertility: a RCT". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03030196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*